|
|
|
| Influence of oral administration of 1200 IU Vitamin D3 on serum vitamin D,bone mineral density and lower extremity function in elderly patients with vitamin D-deficient |
| CHEN Ping-jun1 HUANG Xiao-hong1 WANG Xia1 XIAO Ting1 LIU Qi-sheng2 |
1.Department of Geriatrics,the First People′s Hospital of Jiujiang Ciry,Jiangxi Province,Jiujiang 332000,China;
2.Department of General Surgery,the First People′s Hospital of Jiujiang Ciry,Jiangxi Province,Jiujiang 332000,China |
|
|
|
|
Abstract ObjectiveTo investigate the influence of oral administration of 1200 IU Vitamin D3on serum 25-hydroxyvitamin D[25(OH)D],bone mineral density(BMD)and lower extremity function in elderly patients with vitamin D-deficient.Methods From October 2015 to December 2016,56 elderly patients with vitamin D-deficient treated in our hospital were selected as research subjects.According to vitamin D3took or not,they were divided into the control group(n=29)and observation group(n=27).In the control group,30 min sun bathe daily and proper exercise were necessary.In the observation group,on the basis of the control group,oral administration of Vitamin D3and Caltrate D was added.25(OH)D,osteocalcin,parathyroid hormone,BMD,and walking time of lower extremities were compared between the two groups before intervention,and after 6 and 12 months intervention.Results The serum calcium,serum 25(OH)D,osteocalcin and BMD of the two groups were higher than those before intervention,and after 6 and 12 months intervention,and the above-mentioned indexes in the observation group were all higher than those in the control group (P＜0.05).PTH level after 6 and 12 months intervention in the two groups was lower than that before intervention,and PTH level of in the observation group after 6 and 12 months intervention was lower than in the control group (P＜0.05).The muscle strength of the two groups after intervention was better than that before intervention (P＜0.05).The 8 step walking time after 6 and 12 months intervention in the observation group was longer than that in the control group (P＜0.05).Conclusion O-ral administration of 1200 IU vitamin D3 is beneficial to bone health,and improve BMD as well as the lower limbs function,which has a certain clinical application value and is worthy of promotion and application.
|
|
|
|
|
|
| Cite this article: |
|
CHEN Ping-jun,HUANG Xiao-hong,WANG Xia, et al. Influence of oral administration of 1200 IU Vitamin D3 on serum vitamin D,bone mineral density and lower extremity function in elderly patients with vitamin D-deficient[J]. 中国当代医药, 2018, 25(7): 28-30.
|
|
|
|
| URL: |
| http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I7/28 |
| [12] |
李少卿，王坚.2型糖尿病患者血25-羟维生素D3缺乏对胰岛素抵抗及骨量的影响[J].国际内分泌代谢杂志，2015，35（6）：384-387.
|
| [13] |
陈敏敏，姜鑫，杜艳萍，等.上海社区老年人血清25-羟维生素D水平影响因素的研究[J].中华老年医学杂志，2016，35（9）：1005-1010.
|
| [14] |
王怡，刘逸群，刘丽，等.2型糖尿病患者血清25-羟维生素D3与下肢动脉病变的相关性研究[J].河北医药，2017，39（2）：257-260.
|
| [15] |
吴道爱，王长江，潘攀，等.25-羟维生素D3和血尿酸与2型糖尿病合并下肢动脉病变的相关性分析[J].中国糖尿病杂志，2017，25（5）：429-431.
|
| [8] |
仰曙芬，吴光驰.维生素D缺乏及维生素D缺乏性佝偻病防治建议[J].中国儿童保健杂志，2015，23（7）：781-782.
|
| [9] |
金春华，张丽丽，王晓燕，等.血清25-羟维生素D在诊断婴儿佝偻病的临床意义[J].北京医学，2013，35（10）：824-827.
|
| [10] |
江巍，高凤荣.维生素D缺乏相关性疾病研究进展[J].中国骨质疏松杂志，2014，20（3）：331-337.
|
| [11] |
李冬梅，张颖，丁波，等.血清25羟维生素D缺乏与糖尿病肾病的关系[J].中华内科杂志，2013，52（11）：970-974.
|
| [1] |
游诚，钟燕，赵莎，等.大剂量口服维生素D3治疗婴幼儿维生素D缺乏性佝偻病的临床疗效观察[J].中国医师杂志，2015，17（7）：1088-1091.
|
| [2] |
廖祥鹏，张增利，张红红，等.维生素D与成年人骨骼健康应用指南（2014年简化版）[J].中国骨质疏松杂志，2014，20（6）：718-722.
|
| [3] |
周剑锁，张捷.维生素D临床应用研究进展[J].检验医学，2013，28（6）：539-543.
|
| [4] |
李锦军，陈浩，唐海，等.老年骨质疏松人群维生素D缺乏与跌倒风险关系的研究[J].临床和实验医学杂志，2017，16（5）：482-485.
|
| [5] |
曾晓琼.维生素D缺乏与老年认知功能和日常生活能力关系研究[J].九江学院学报（自然科学版），2014，29（1）：84-85.
|
| [6] |
吴青，朱汉民.骨质疏松基础防治措施对老年人25羟基维生素D水平和下肢肌力及平衡功能的影响[J].中华老年医学杂志，2014，33（10）：1135-1138.
|
| [7] |
赵丽平，陈绩，杨婷，等.儿童维生素D缺乏症药物治疗循证指南的系统评价[J].中国循证医学杂志，2015，15（3）：270-275.
|
|
|
|
